Abstract
The European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) is the world's leading congress in infectious diseases, attracting nearly 13,000 delegates in 2018. Cytomegalovirus was a major topic for discussion, since it remains an important cause of morbidity and mortality in transplant recipients. In the future, novel diagnostic technologies and new antiviral drugs may help to reduce the risk of post-transplant cytomegalovirus infection and disease, and so improve outcomes for patients. Report from the 28th European Congress of Clinical Microbiology and Infectious Diseases (European Congress of Clinical Microbiology and Infectious Diseases 2018), Madrid, Spain, 21–24 April 2018.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
